Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.

Autor: Chervo TC; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Elkin EP; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Nugent JR; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Valice E; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Amsden LB; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Ergas IJ; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Munneke JR; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Flores M; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Saelee GN; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Hsiao CA; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Schapiro JM; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, California, United States of America., Quesenberry CP; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Corley DA; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, California, United States of America., Habel LA; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America., Skarbinski J; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, California, United States of America.; Department of Infectious Diseases, Oakland Medical Center, Kaiser Permanente Northern California, Oakland, California, United States of America.; Physician Researcher Program, Kaiser Permanente Northern California, Oakland, California, United States of America.

Publikováno v: PloS one [PLoS One] 2024 Jun 20; Vol. 19 (6), pp. e0303303. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).